Assessments, Treatments and Modeling in Aging and Neurological Disease
The Neuroscience of Aging
Herausgeber: R Martin, Colin; Rajendram, Rajkumar; Preedy, Victor R
Assessments, Treatments and Modeling in Aging and Neurological Disease
The Neuroscience of Aging
Herausgeber: R Martin, Colin; Rajendram, Rajkumar; Preedy, Victor R
- Gebundenes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Assessments, Treatments and Modeling in Aging and Neurological Disease: The Neuroscience of Aging is a comprehensive reference on the diagnosis and management of neurological aging and associated disorders. The book discusses the mechanisms underlying neurological aging and provides readers with a detailed introduction to the aging of neural connections and complexities in biological circuitries, as well as the interactions between genetics, epigenetics and other micro-environmental processes. It also examines pharmacological and non-pharmacological interventions of age-related conditions that…mehr
- Diagnosis, Management and Modeling of Neurodevelopmental Disorders265,99 €
- Factors Affecting Neurodevelopment268,99 €
- Capute and Accardo's Neurodevelopmental Disabilities in Infancy and Childhood216,99 €
- Neural Circuit and Cognitive Development239,99 €
- Handbook of Nutrition, Diet, and the Eye212,99 €
- Nerves and Nerve Injuries186,99 €
- Evaluation and Assessment of Autism Spectrum Disorder156,99 €
-
-
-
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
- Produktdetails
- Verlag: Elsevier Science
- Seitenzahl: 606
- Erscheinungstermin: 25. Juni 2021
- Englisch
- Gewicht: 1860g
- ISBN-13: 9780128180006
- ISBN-10: 0128180005
- Artikelnr.: 61936281
- Herstellerkennzeichnung
- Libri GmbH
- Europaallee 1
- 36244 Bad Hersfeld
- 06621 890
- Verlag: Elsevier Science
- Seitenzahl: 606
- Erscheinungstermin: 25. Juni 2021
- Englisch
- Gewicht: 1860g
- ISBN-13: 9780128180006
- ISBN-10: 0128180005
- Artikelnr.: 61936281
- Herstellerkennzeichnung
- Libri GmbH
- Europaallee 1
- 36244 Bad Hersfeld
- 06621 890
1. The concept of productive aging2. Quality of life in the over 80s3.
Successful aging and diet4. The impact of positive social relations on the
quality of life of older people. An alternative to medicalization from an
integral perspective5. The brain in life span: Use of phase fMagnetic
Resonance Imaging (MRI)6. Neuronal structure in aging: cytoskeleton in
health and disease7. Sporadic Alzheimer's Triad: Age, Sex, and ApoE8. How
polymorphisms impact: BDNF polymorphism, inhibitory performance and the
elderly9. Menopause as an aging process and alcohol misuse10. Brain banking
and aging
II. Impairments and Diseases11. Dementia or no dementia in the very
elderly. Why?12. Neuropsychology, Social Cognition and Loss of Insight in
Frontotemporal Dementia13. Neuroinflammation in the elderly14. Cortical
microinfarcts and the aging brain15. Vascular brain injury and
neurodegeneration in elderly racial and ethnic minority populations16.
Hearing loss amongst the elderly17. Aging Auditory Cortex: The Impact of
Reduced Inhibition on Function18. Aging and vestibular disorders19. Brain
aging in HIV and antiretrovirals 20. Antioxidants, Methylmercury, and
Aging21. Aging and the effects of ethanol on the brain: Comparing the
effects of different aging
III. Biomarkers and Diagnosis 22. Aging brain: Radiological biomarkers23.
Plasma ADAM10 as a biomarker of mental impairment in the elderly24.
Circulating microRNAs as biomarkers of healthy elderly25. DHEA as a
biomarker of aging in humans and nonhuman primates: Synthesis,
neuroprotection and cognitive function26. Evaluation of subjective memory
abilities in elderly people27. The Functional Activities Questionnaire:
Applications to aging28. Autobiographical memory as a diagnostic tool in
aging29. Assessment tools for subjective memory abilities in elderly
people30. Knowledge of Memory Aging
IV. Management and Treatments31. Pharmacological use of transient receptor
potential (TRP) ion channel antagonists in neurological disease: Effects on
swallowing and implications for nutrition32. Aripiprazole: Features and use
in the aged33. Cognition-Enhancing Drugs and Applications to Aging34.
Creatine supplementation and impact on the aging brain35.
Photobiomodulation as a brain-boosting strategy in aging36. Innovation in
deep brain stimulation in aging: a focus on Parkinson Disease37. Exergames:
What they are and how they can be used to improve cognition in aging38.
Linking cognitive decline and ballroom dance as a therapeutic intervention
in the elderly39. Active experiencing training in the elderly40.
Psychiatric self-management, smartphone apps and older adults41.
Psychosocial Interventions for Suicide Prevention in the Elderly: Advances
and Future Directions
V. Models and Modelling42. D-galactose-induced aging and brain
mitochondria43. Drosophila as a model organism in ageing research44. The
Zebrafish (Danio rerio) and its uses for understanding the neuroscience of
aging: applications and observation45. Murine models of primary Tauopathy
as a model of aging46. Modelling nutrition and brain aging in rodents47.
Modelling primates and neurological aging: A focus on Alzheimer's
disease48. Linking aging and animal models to neurodegeneration: The
Striatum, Substantia Nigra and Parkinson's Disease49. Behavioral evaluation
of aging
VI. Resources50. Research and recommended resources in the neuroscience of
aging
1. The concept of productive aging2. Quality of life in the over 80s3.
Successful aging and diet4. The impact of positive social relations on the
quality of life of older people. An alternative to medicalization from an
integral perspective5. The brain in life span: Use of phase fMagnetic
Resonance Imaging (MRI)6. Neuronal structure in aging: cytoskeleton in
health and disease7. Sporadic Alzheimer's Triad: Age, Sex, and ApoE8. How
polymorphisms impact: BDNF polymorphism, inhibitory performance and the
elderly9. Menopause as an aging process and alcohol misuse10. Brain banking
and aging
II. Impairments and Diseases11. Dementia or no dementia in the very
elderly. Why?12. Neuropsychology, Social Cognition and Loss of Insight in
Frontotemporal Dementia13. Neuroinflammation in the elderly14. Cortical
microinfarcts and the aging brain15. Vascular brain injury and
neurodegeneration in elderly racial and ethnic minority populations16.
Hearing loss amongst the elderly17. Aging Auditory Cortex: The Impact of
Reduced Inhibition on Function18. Aging and vestibular disorders19. Brain
aging in HIV and antiretrovirals 20. Antioxidants, Methylmercury, and
Aging21. Aging and the effects of ethanol on the brain: Comparing the
effects of different aging
III. Biomarkers and Diagnosis 22. Aging brain: Radiological biomarkers23.
Plasma ADAM10 as a biomarker of mental impairment in the elderly24.
Circulating microRNAs as biomarkers of healthy elderly25. DHEA as a
biomarker of aging in humans and nonhuman primates: Synthesis,
neuroprotection and cognitive function26. Evaluation of subjective memory
abilities in elderly people27. The Functional Activities Questionnaire:
Applications to aging28. Autobiographical memory as a diagnostic tool in
aging29. Assessment tools for subjective memory abilities in elderly
people30. Knowledge of Memory Aging
IV. Management and Treatments31. Pharmacological use of transient receptor
potential (TRP) ion channel antagonists in neurological disease: Effects on
swallowing and implications for nutrition32. Aripiprazole: Features and use
in the aged33. Cognition-Enhancing Drugs and Applications to Aging34.
Creatine supplementation and impact on the aging brain35.
Photobiomodulation as a brain-boosting strategy in aging36. Innovation in
deep brain stimulation in aging: a focus on Parkinson Disease37. Exergames:
What they are and how they can be used to improve cognition in aging38.
Linking cognitive decline and ballroom dance as a therapeutic intervention
in the elderly39. Active experiencing training in the elderly40.
Psychiatric self-management, smartphone apps and older adults41.
Psychosocial Interventions for Suicide Prevention in the Elderly: Advances
and Future Directions
V. Models and Modelling42. D-galactose-induced aging and brain
mitochondria43. Drosophila as a model organism in ageing research44. The
Zebrafish (Danio rerio) and its uses for understanding the neuroscience of
aging: applications and observation45. Murine models of primary Tauopathy
as a model of aging46. Modelling nutrition and brain aging in rodents47.
Modelling primates and neurological aging: A focus on Alzheimer's
disease48. Linking aging and animal models to neurodegeneration: The
Striatum, Substantia Nigra and Parkinson's Disease49. Behavioral evaluation
of aging
VI. Resources50. Research and recommended resources in the neuroscience of
aging